JMJD5 regulates cell cycle and pluripotency in human embryonic stem cells

Stem Cells

Volumn 32, Issue 8, 2014, Pages 2098-2110

  Zhu, Hui ^a   Hu, Shijun ^a   Baker, Julie ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

CDKN1A (p21); G1 phase; Human embryonic stem cells; JMJD5; Pluripotency

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; JMJD5 PROTEIN; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; HISTONE DEMETHYLASE; KDM8 PROTEIN, HUMAN; TRANSCRIPTOME;

ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL LINEAGE; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDODERM; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PHENOTYPE; PLURIPOTENT STEM CELL; UPREGULATION; CELL CYCLE; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; FLOW CYTOMETRY; GENETIC TRANSDUCTION; METABOLISM; PHYSIOLOGY; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HISTONE DEMETHYLASES; HUMANS; PLURIPOTENT STEM CELLS; RNA, SMALL INTERFERING; TRANSCRIPTOME; TRANSDUCTION, GENETIC;

EID: 84904429667     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1724     Document Type: Article

References (77)

1. White J, Dalton S,. Cell cycle control of embryonic stem cells. Stem Cell Rev 2005; 1: 131-138.
2. Orford KW, Scadden DT,. Deconstructing stem cell self-renewal: Genetic insights into cell-cycle regulation. Nat Rev Genet 2008; 9: 115-128.
3. Ruiz S, Panopoulos AD, Herrerias A, et al. A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol 2011; 21: 45-52.
4. Kapinas K, Grandy R, Ghule P, et al. The abbreviated pluripotent cell cycle. J Cell Physiol 2013; 228: 9-20.
5. Neganova I, Lako M,. G1 to S phase cell cycle transition in somatic and embryonic stem cells. J Anat 2008; 213: 30-44.
6. Singh AM, Dalton S,. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 2009; 5: 141-149.
7. Edel MJ, Izpisua Belmonte JC,. The cell cycle and pluripotency: Is there a direct link? Cell Cycle 2010; 9: 2694-2695.
8. Becker KA, Ghule PN, Therrien JA, et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol 2006; 209: 883-893.
9. Becker KA, Stein JL, Lian JB, et al. Establishment of histone gene regulation and cell cycle checkpoint control in human embryonic stem cells. J Cell Physiol 2007; 210: 517-526.
10. Ghule PN, Dominski Z, Yang XC, et al. Staged assembly of histone gene expression machinery at subnuclear foci in the abbreviated cell cycle of human embryonic stem cells. Proc Natl Acad Sci USA 2008; 105: 16964-16969.
11. Ghule PN, Medina R, Lengner CJ, et al. Reprogramming the pluripotent cell cycle: Restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells. J Cell Physiol 2011; 226: 1149-1156.
12. Becker KA, Stein JL, Lian JB, et al. Human embryonic stem cells are pre-mitotically committed to self-renewal and acquire a lengthened G1 phase upon lineage programming. J Cell Physiol 2010; 222: 103-110.
13. Calder A, Roth-Albin I, Bhatia S, et al. Lengthened g1 phase indicates differentiation status in human embryonic stem cells. Stem Cells Dev 2013; 22: 279-295.
14. Lange C, Calegari F,. Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells. Cell Cycle 2010; 9: 1893-1900.
15. Stead E, White J, Faast R, et al. Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 2002; 21: 8320-8333.
16. Neganova I, Zhang X, Atkinson S, et al. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Oncogene 2009; 28: 20-30.
17. Sengupta S, Nie J, Wagner RJ, et al. MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 2009; 27: 1524-1528.
18. Harper JW, Adami GR, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
19. Xiong Y, Hannon GJ, Zhang H, et al. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701-704.
20. Reed SI, Bailly E, Dulic V, et al. G1 control in mammalian cells. J Cell Sci Suppl 1994; 18: 69-73.
21. Sherr CJ, Roberts JM,. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149-1163.
22. Egozi D, Shapira M, Paor G, et al. Regulation of the cell cycle inhibitor p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells. FASEB J 2007; 21: 2807-2817.
23. Menchon C, Edel MJ, Izpisua Belmonte JC,. The cell cycle inhibitor p27Kip(1) controls self-renewal and pluripotency of human embryonic stem cells by regulating the cell cycle, Brachyury and Twist. Cell Cycle 2011; 10: 1435-1447.
24. Neganova I, Vilella F, Atkinson SP, et al. An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells 2011; 29: 651-659.
25. Maimets T, Neganova I, Armstrong L, et al. Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells. Oncogene 2008; 27: 5277-5287.
26. Koledova Z, Kafkova LR, Calabkova L, et al. Cdk2 inhibition prolongs G1 phase progression in mouse embryonic stem cells. Stem Cells Dev 2010; 19: 181-194.
27. Kawamura T, Suzuki J, Wang YV, et al. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009; 460: 1140-1144.
28. Hanna J, Saha K, Pando B, et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009; 462: 595-601.
29. Hong H, Takahashi K, Ichisaka T, et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009; 460: 1132-1135.
30. Wang Y, Baskerville S, Shenoy A, et al. Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 2008; 40: 1478-1483.
31. Dolezalova D, Mraz M, Barta T, et al. MicroRNAs regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human embryonic stem cells. Stem Cells 2012; 30: 1362-1372.
32. Li W, Zhao L, Zang W, et al. Histone demethylase JMJD2B is required for tumor cell proliferation and survival and is overexpressed in gastric cancer. Biochem Biophys Res Commun 2011; 416: 372-378.
33. Ishimura A, Minehata K, Terashima M, et al. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Development 2012; 139: 749-759.
34. Kim TD, Shin S, Berry WL, et al. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells. J Cell Biochem 2012; 113: 1368-1376.
35. Wong PP, Miranda F, Chan KV, et al. Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A). Mol Cell Biol 2012; 32: 1633-1644.
36. Lee J, Go Y, Kang I, et al. Oct-4 controls cell-cycle progression of embryonic stem cells. Biochem J 2010; 426: 171-181.
37. Tsukada Y, Fang J, Erdjument-Bromage H, et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 2006; 439: 811-816.
38. Yamane K, Toumazou C, Tsukada Y, et al. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 2006; 125: 483-495.
39. Whetstine JR, Nottke A, Lan F, et al. Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell 2006; 125: 467-481.
40. Cloos PA, Christensen J, Agger K, et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 2006; 442: 307-311.
41. Fodor BD, Kubicek S, Yonezawa M, et al. Jmjd2b antagonizes H3K9 trimethylation at pericentric heterochromatin in mammalian cells. Genes Dev 2006; 20: 1557-1562.
42. Klose RJ, Yamane K, Bae Y, et al. The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature 2006; 442: 312-316.
43. Shi Y, Whetstine JR,. Dynamic regulation of histone lysine methylation by demethylases. Mol Cell 2007; 25: 1-14.
44. Iwase S, Lan F, Bayliss P, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 2007; 128: 1077-1088.
45. Mosammaparast N, Shi Y,. Reversal of histone methylation: Biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 2010; 79: 155-179.
46. Schofield CJ, Ratcliffe PJ,. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
47. Webby CJ, Wolf A, Gromak N, et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 2009; 325: 90-93.
48. Noma A, Ishitani R, Kato M, et al. Expanding role of the jumonji C domain as an RNA hydroxylase. J Biol Chem 2010; 285: 34503-34507.
49. Kato M, Araiso Y, Noma A, et al. Crystal structure of a novel JmjC-domain-containing protein, TYW5, involved in tRNA modification. Nucleic Acids Res 2011; 39: 1576-1585.
50. Mantri M, Loik ND, Hamed RB, et al. The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues. Chembiochem 2011; 12: 531-534.
51. Del Rizzo PA, Krishnan S, Trievel RC,. Crystal structure and functional analysis of JMJD5 indicate an alternate specificity and function. Mol Cell Biol 2012; 32: 4044-4052.
52. Youn MY, Yokoyama A, Fujiyama-Nakamura S, et al. JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation. J Biol Chem 2012; 287: 12994-13004.
53. Loh YH, Zhang W, Chen X, et al. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev 2007; 21: 2545-2557.
54. Dahle O, Kumar A, Kuehn MR,. Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes. Sci Signal 2010; 3: ra48.
55. Hsia DA, Tepper CG, Pochampalli MR, et al. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc Natl Acad Sci USA 2010; 107: 9671-9676.
56. Oh S, Janknecht R,. Histone demethylase JMJD5 is essential for embryonic development. Biochem Biophys Res Commun 2012; 420: 61-65.
57. Brunner AL, Johnson DS, Kim SW, et al. Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res 2009; 19: 1044-1056.
58. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol 2006; 24: 1392-1401.
59. D'Amour KA, Agulnick AD, Eliazer S, et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 2005; 23: 1534-1541.
60. Kim SW, Yoon SJ, Chuong E, et al. Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev Biol 2011; 357: 492-504.
61. Rubinson DA, Dillon CP, Kwiatkowski AV, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003; 33: 401-406.
62. Beck AH, Weng Z, Witten DM, et al. 3'-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS One 2010; 5: e8768.
63. Foley JW, Sidow A,. Transcription-factor occupancy at HOT regions quantitatively predicts RNA polymerase recruitment in five human cell lines. BMC Genomics 2013; 14: 720.
64. Fluckiger AC, Marcy G, Marchand M, et al. Cell cycle features of primate embryonic stem cells. Stem Cells 2006; 24: 547-556.
65. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, et al. Embryonic stem cell-specific miR302-367 cluster: Human gene structure and functional characterization of its core promoter. Mol Cell Biol 2008; 28: 6609-6619.
66. Ivanovska I, Ball AS, Diaz RL, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 2008; 28: 2167-2174.
67. Suh MR, Lee Y, Kim JY, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004; 270: 488-498.
68. Card DA, Hebbar PB, Li L, et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008; 28: 6426-6438.
69. Barroso-del Jesus A, Lucena-Aguilar G, Menendez P,. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle 2009; 8: 394-398.
70. Anokye-Danso F, Trivedi CM, Juhr D, et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011; 8: 376-388.
71. Kim VN,. Cell cycle micromanagement in embryonic stem cells. Nat Genet 2008; 40: 1391-1392.
72. Boheler KR,. Stem cell pluripotency: A cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle. J Cell Physiol 2009; 221: 10-17.
73. Sela Y, Molotski N, Golan S, et al. Human embryonic stem cells exhibit increased propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein. Stem Cells 2012; 30: 1097-1108.
74. Coronado D, Godet M, Bourillot PY, et al. A short G1 phase is an intrinsic determinant of naive embryonic stem cell pluripotency. Stem Cell Res 2013; 10: 118-131.
75. Pauklin S, Vallier L,. The cell-cycle state of stem cells determines cell fate propensity. Cell 2013; 155: 135-147.
76. Li VC, Ballabeni A, Kirschner MW,. Gap 1 phase length and mouse embryonic stem cell self-renewal. Proc Natl Acad Sci USA 2012; 109: 12550-12555.
77. Medina R, Ghule PN, Cruzat F, et al. Epigenetic control of cell cycle-dependent histone gene expression is a principal component of the abbreviated pluripotent cell cycle. Mol Cell Biol 2012; 32: 3860-3871.